This week, we will be discussing a randomized controlled trial of eculizumab in STEC-HUS. Will eculizumab manage to surpass its well-established reputation as expensivumab and demonstrate some positive results?
The 2021 KDIGO GN Guidelines
A SSaSSy Visual Abstract
shweta shah did an amazing job on this week’s visual abstract.